Randomized phase II cross-over sequential chemotherapy trial of irinotecan/cisplatin (IP) vs. gemcitabine/vinorelbine (GV) in chemo-naive patients with stage IIIb/IV non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Lee, J. S. [1 ]
Lee, D. H. [1 ]
Lee, J. J. [1 ]
Han, J. Y. [1 ]
Park, S. H. [1 ]
Song, J. E. [1 ]
Kim, H. Y. [1 ]
Kim, H. T. [1 ]
机构：
[1] Natl Canc Ctr Hosp, Goyang Gyeonggi, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7134
引用
收藏
页码：397S / 397S
页数：1
相关论文
共 50 条
  • [31] Gemcitabine (G) as a single drug versus gemcitabine plus vinerolbine (GV) for non-small cell lung cancer (NSCLC) stage IIIB and IV
    Raquel, Gerson
    Serrano, Alberto
    Villalobos, Alberto
    ANNALS OF ONCOLOGY, 2004, 15 : 195 - 195
  • [32] A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan
    Chen, Yuh-Min
    Perng, Reury-Perng
    Shih, Jen-Fu
    Tsai, Chun-Ming
    Whang-Peng, Jacqueline
    LUNG CANCER, 2007, 56 (03) : 363 - 369
  • [33] A randomized phase iib trial of gemcitabine and cisplatin (GC) versus gemcitabine and docetaxel (GD) in stage IIIB/IV advanced non-small cell lung cancer (NSCLC) -: An Galician lung cancer group study
    Rubio, J. Casal
    Estevez, S. Vazquez
    Rivera, F. Vazquez
    Salfago, Mercedes
    Llorca, Cristina
    Ramos, Manuel
    Perez, Eva
    Cervera, Jose M.
    Garcia, Jesus
    Gomez, Jesus Garcia
    Mata, Jesus Garcia
    ANNALS OF ONCOLOGY, 2006, 17 : 224 - 224
  • [34] Second-line chemotherapy with irinotecan and vinorelbine in stage IIIB and IV non-small-cell lung cancer -: A phase II study
    Cao, MG
    Aramendía, JM
    Salgado, E
    Aristu, J
    Monje, RM
    Algarra, SM
    Ordoñez, JM
    Brugarolas, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 480 - 484
  • [35] Neoadjuvant chemotherapy with navelbine (NVB) plus cisplatin (C) in stage IIIB in non-small cell lung cancer (NSCLC): A phase II trial
    Cigolari, S
    Curcio, C
    Massimo, M
    Sessa, R
    Vasta, M
    Maiorino, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1090 - 1090
  • [36] Randomized phase II study of two different schedules of gemcitabine and oral TS-1 in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Satouchi, M.
    Kotani, Y.
    Katakami, N.
    Shimada, T.
    Urata, Y.
    Yoshimura, S.
    Funada, Y.
    Hata, A.
    Ando, M.
    Negoro, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] UFT after sequential chemo and radiotherapy in patients with stage IIIB non-small cell lung cancer (NSCLC).
    Martins, R
    De Biase, P
    Toscano, E
    Madeira, D
    Pereira, C
    Cavalcante, A
    Pinel, I
    Roriz, W
    Zukin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 689S - 689S
  • [38] A phase II study of weekly irinotecan plus capecitabine for chemo-naive patients with advanced non-small cell lung cancer.
    Kim, HT
    Han, JY
    Lee, DH
    Lee, SY
    Park, CG
    Kim, HY
    Lee, HG
    Lee, JJ
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 653S - 653S
  • [39] Taxol plus gemcitabine and vinorelbine given every other week in advanced chemo-naive non-small cell lung cancer patients
    Frasci, G
    Comella, P
    De Cataldis, G
    Maiorino, L
    Fiore, F
    De Rosa, V
    Lapenta, L
    Licenziato, M
    Comella, G
    ONCOLOGY, 2003, 65 (04) : 378 - 379
  • [40] Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer
    Clark, JI
    Kancharla, K
    Qamar, R
    Fisher, S
    Hantel, A
    Panganiban, J
    Millbrandt, L
    Albain, KS
    LUNG CANCER, 2001, 34 (02) : 271 - 277
12345